| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |